Stockscreener 앱 받기
1.29
0.77%
-0.01
시간 외 거래:
1.36
0.07
+5.43%
전일 마감가:
$1.30
열려 있는:
$1.33
하루 거래량:
473.03K
Relative Volume:
0.59
시가총액:
$129.26M
수익:
$31.20M
순이익/손실:
$-21.68M
주가수익비율:
-5.2826
EPS:
-0.2442
순현금흐름:
$-15.52M
1주 성능:
-7.19%
1개월 성능:
-11.64%
6개월 성능:
-33.16%
1년 성능:
-55.21%
1일 변동 폭
$1.28
$1.35
1주일 범위
$1.265
$1.40
52주 변동 폭
$1.24
$3.59
Stereotaxis Inc Stock (STXS) Company Profile
명칭
Stereotaxis Inc
전화
314-678-6100
주소
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
1.29 | 129.26M | 31.20M | -21.68M | -15.52M | -0.2442 |
ISRG
Intuitive Surgical Inc
|
369.15 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
177.85 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.03 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.27 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
32.53 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 개시 | Citizens JMP | Mkt Outperform |
| 2024-01-10 | 개시 | ROTH MKM | Buy |
| 2022-07-12 | 개시 | Aegis Capital | Buy |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2022-01-05 | 개시 | Craig Hallum | Buy |
| 2022-01-05 | 개시 | Loop Capital | Buy |
| 2021-05-26 | 개시 | Piper Sandler | Overweight |
| 2020-09-08 | 개시 | Northland Capital | Outperform |
| 2020-04-09 | 개시 | Cowen | Outperform |
| 2020-04-07 | 개시 | Lake Street | Buy |
모두보기
Stereotaxis Inc 주식(STXS)의 최신 뉴스
Earnings Preview: Stereotaxis to Report Financial Results Post-market on August 11 - Moomoo
Stereotaxis Stock Price Forecast. Should You Buy STXS? - StockInvest.us
Stereotaxis: A Real Product Story, But The Stock Already Prices In Success (NYSE:STXS) - Seeking Alpha
July launch by Stereotaxis achieves 70 cases treating full arrhythmia spectrum - Traders Union
A Hungarian hospital treated over 70 heart patients with robots in just over a month - Stock Titan
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program - Yahoo Finance
Stereotaxis Inc (STXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Citizens JMP Maintains Stereotaxis(STXS.US) With Buy Rating, Cuts Target Price to $3 - Moomoo
Stereotaxis (STXS) Q2 2026 Earnings Call Transcript - AOL.com
Stereotaxis (STXS) Update: Ends Lower by 1.39% at $1.42 in the Current Update; Market Levels: the $1.35 to $1.49 Range Remains in Focus at the CloseAdvance Decline Volume - dars.gov.et
New >5% shareholder emerges in Stereotaxis (STXS) stock - Stock Titan
Stereotaxis, Inc. momentum grows in robotic electrophysiology as sector approaches inflection point - Traders Union
Robot performs 26 cataract surgeries with surgeon control - AOL.com
STXS|Stereotaxis Inc|Price:1.395|Chg%:+0.035 - TradingKey
Stereotaxis Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Stereotaxis, Inc. engages with medical leaders at KCHRS event - Traders Union
Stereotaxis, Inc. introduces MAGiC ablation tip for efficient energy delivery - Traders Union
Stereotaxis, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Stereotaxis (STXS) Stock Sees Little Reward For Recurring Revenue Progress - Sahm
STXS Q2 2026 Earnings: Narrow EPS Beat Overshadowed by 4.11% Share SlideTangible Book Value - vinanet.vn
Stereotaxis, Inc. completes Robocath deal as GenesisX gains first U.S. customer - Traders Union
Stereotaxis, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Stereotaxis Q2 Earnings Call Highlights - TradingView
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Is Stereotaxis Inc (STXS) Undervalued Despite Q2 Revenue Miss? G - GuruFocus
Stereotaxis robotic catheter sales surge 270% in Q2 despite revenue miss - scanx.trade
Transcript : Stereotaxis, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates - The Manila Times
Stereotaxis Q2 revenue misses estimates, dragged by system decline - tradingview.com
Stereotaxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Stereotaxis’ First U.S. GenesisX Robot to Be Installed This Fall - Stock Titan
BRIEF-Stereotaxis Q2 Revenue USD 7.67 Million Vs. IBES Estimate USD 8.35 Million - TradingView
Stereotaxis Inc (STXS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Stereotaxis Inc (RJR1.DU) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Enterprise value to revenue forward of Stereotaxis, Inc. – FWB:RJR1 - TradingView
Stereotaxis, Inc. brings GenesisX robot for community heart health education in St. Louis - tradersunion.com
Stereotaxis (STXS) Projected to Release Quarterly Earnings on Tuesday - marketbeat.com
Stereotaxis Inc (STXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Stereotaxis Inc (STXS) Institutional Confidence - TradingKey
STXS Q1 2026 Earnings: EPS Misses Estimates Amid Limited Financial VisibilityHealthcare Earnings Report - vinanet.vn
Stereotaxis Inc (STXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Stereotaxis Inc (STXS) Cash Flow - TradingKey
Stereotaxis Inc (STXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Stereotaxis Inc (STXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
STXS|Stereotaxis Inc|Price:1.260|Chg%:-0.070 - TradingKey
STXS Q1 2026 Earnings: EPS Miss Sparks 8.5% Stock DeclineEarnings Yield Spread - vinanet.vn
STXS|Stereotaxis Inc|Price:1.300|Chg%:+0.010 - TradingKey
Stereotaxis Inc (STXS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Stereotaxis Inc (STXS) Balance Sheet - TradingKey
Stereotaxis, Inc. Revenue Breakdown – AMEX:STXS - TradingView
Stereotaxis Inc. (STXS) Stock Price | Live Quotes & Charts | AMEX - timothysykes.com
Stereotaxis Inc (STXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.48%
0.07%
자본화:
|
볼륨(24시간):